Tag: Zydus Lifesciences Limited

Mar 12

Zydus Gets USFDA Approval for Methenamine Hippurate Tablets USP, 1g

teamLeave a Comment on Zydus Gets USFDA Approval for Methenamine Hippurate Tablets USP, 1gPosted in Business Tagged

Ahmedabad, India, 12 March, 2025 Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram (USRLD: Hiprex® Tablets, 1 gram). Methenamine Hippurate tablets are indicated for prophylactic or suppressive treatment of frequently […]